Baldwin Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5M Buy
9,982
+1,880
+23% +$902K 0.48% 33
2026
Q1
$3.98M Sell
8,102
-10
-0.1% -$5.43K 0.47% 34
2025
Q4
$4.7M Sell
8,112
-138
-2% -$78K 0.53% 28
2025
Q3
$4M Buy
8,250
+10
+0.1% +$4.66K 0.46% 31
2025
Q2
$3.34M Sell
8,240
-694
-8% -$290K 0.4% 35
2025
Q1
$4.45M Buy
8,934
+55
+0.6% +$29.8K 0.53% 24
2024
Q4
$4.62M Buy
8,879
+1,119
+14% +$615K 0.6% 23
2024
Q3
$4.8M Sell
7,760
-108
-1% -$63.9K 0.6% 21
2024
Q2
$4.35M Buy
7,868
+100
+1% +$57.3K 0.6% 20
2024
Q1
$4.51M Buy
7,768
+245
+3% +$137K 0.61% 19
2023
Q4
$3.99M Buy
7,523
+190
+3% +$92K 0.62% 22
2023
Q3
$3.71M Buy
7,333
+40
+0.5% +$21.3K 0.62% 19
2023
Q2
$3.81M Sell
7,293
-365
-5% -$197K 0.63% 21
2023
Q1
$4.41M Buy
7,658
+23
+0.3% +$13K 0.78% 14
2022
Q4
$4.2M Buy
7,635
+140
+2% +$74.2K 0.76% 17
2022
Q3
$3.8K Sell
7,495
-168
-2% -$94K 0.77% 16
2022
Q2
$4.16K Sell
7,663
-368
-5% -$203K 0.79% 15
2022
Q1
$4.74K Sell
8,031
-355
-4% -$204K 0.72% 18
2021
Q4
$5.6K Sell
8,386
-4
-0% -$2.5K 0.87% 14
2021
Q3
$4.79M Sell
8,390
-117
-1% -$64.2K 0.83% 12
2021
Q2
$4.29M Buy
8,507
+357
+4% +$168K 0.73% 20
2021
Q1
$3.72M Sell
8,150
-20
-0.2% -$9.55K 0.68% 22
2020
Q4
$3.81M Buy
8,170
+330
+4% +$155K 0.75% 22
2020
Q3
$3.46M Buy
7,840
+1,010
+15% +$417K 0.81% 17
2020
Q2
$2.48M Sell
6,830
-100
-1% -$33.5K 0.78% 21
2020
Q1
$1.97M Sell
6,930
-150
-2% -$47.3K 0.68% 21
2019
Q4
$2.3M Hold
7,080
0.62% 21
2019
Q3
$2.06M Sell
7,080
-200
-3% -$57.3K 0.6% 22
2019
Q2
$2.14M Sell
7,280
-150
-2% -$41.3K 0.62% 18
2019
Q1
$2.03M Sell
7,430
-442
-6% -$110K 0.61% 20
2018
Q4
$1.76M Sell
7,872
-350
-4% -$82.1K 0.56% 18
2018
Q3
$2.01M Hold
8,222
0.57% 20
2018
Q2
$1.7M Buy
8,222
+25
+0.3% +$5.31K 0.54% 23
2018
Q1
$1.69M Sell
8,197
-325
-4% -$68.2K 0.61% 20
2017
Q4
$1.62M Sell
8,522
-50
-0.6% -$9.58K 0.58% 20
2017
Q3
$1.62M Hold
8,572
0.61% 15
2017
Q2
$1.5M Sell
8,572
-650
-7% -$109K 0.6% 17
2017
Q1
$1.42M Sell
9,222
-762
-8% -$116K 0.55% 20
2016
Q4
$1.41M Sell
9,984
-305
-3% -$45K 0.56% 21
2016
Q3
$1.64M Sell
10,289
-250
-2% -$38.5K 0.7% 13
2016
Q2
$1.56M Sell
10,539
-343
-3% -$50.6K 0.67% 17
2016
Q1
$1.54M Hold
10,882
0.66% 16
2015
Q4
$1.54M Sell
10,882
-133
-1% -$17.7K 0.69% 17
2015
Q3
$1.35M Buy
11,015
+105
+1% +$13.7K 0.59% 19
2015
Q2
$1.42M Sell
10,910
-150
-1% -$19.6K 0.59% 20
2015
Q1
$1.49M Buy
11,060
+630
+6% +$81.2K 0.59% 20
2014
Q4
$1.31M Buy
10,430
+130
+1% +$15.8K 0.51% 27
2014
Q3
$1.25M Hold
10,300
0.52% 25
2014
Q2
$1.22M Sell
10,300
-125
-1% -$14.7K 0.53% 25
2014
Q1
$1.25M Sell
10,425
-325
-3% -$38.6K 0.56% 22
2013
Q4
$1.2M Sell
10,750
-100
-0.9% -$9.94K 0.54% 24
2013
Q3
$1M Sell
10,850
-125
-1% -$11.3K 0.48% 27
2013
Q2
$929K Buy
+10,975
New +$914K 0.46% 30

Other funds holding TMO

Baldwin Investment Management's TMO Position: Q2 2026 in Review

Baldwin Investment Management increased its Thermo Fisher Scientific (TMO) stake by 23% in Q2 2026, buying an estimated $902K and bringing the position to 9,982 shares worth $5M. The position accounts for 0.48% of the portfolio, ranked #33.

Baldwin Investment Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Baldwin Investment Management held 9,982 shares of Thermo Fisher Scientific worth $5M as of Q2 2026.
  • Baldwin Investment Management bought 1,880 Thermo Fisher Scientific shares in Q2 2026, an estimated $902K.
  • Thermo Fisher Scientific made up 0.48% of Baldwin Investment Management's portfolio in Q2 2026, its #33 holding.
  • Baldwin Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Baldwin Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.